title: Osteoprotegerin levels are increased in patients with venous thromboembolic disease.
authors.forename: M
authors.initials: M
authors.lastname: Rattazzi
authors.forename: E
authors.initials: E
authors.lastname: Faggin
authors.forename: S
authors.initials: S
authors.lastname: Galliazzo
authors.forename: M
authors.initials: M
authors.lastname: Puato
authors.forename: L
authors.initials: L
authors.lastname: Caberlotto
authors.forename: G
authors.initials: G
authors.lastname: Scannapieco
authors.forename: S
authors.initials: S
authors.lastname: Villalta
authors.forename: P
authors.initials: P
authors.lastname: Pauletto
mesh_terms: D000328:Adult; D000368:Aged; D015415:Biomarkers / Q000097:blood; D016009:Chi-Square Distribution; D005260:Female; D006801:Humans; D007558:Italy / Q000453:epidemiology; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D016017:Odds Ratio; D053244:Osteoprotegerin / Q000097:blood*; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D015854:Up-Regulation; D054556:Venous Thromboembolism / Q000097:blood* / Q000453:epidemiology
chemical_list: D015415:Biomarkers; D053244:Osteoprotegerin; C506030:TNFRSF11B protein, human